Oral nafazatrom in man: effect on inhaled antigen challenge (Q34416543)

2 August 2017

title

Oral nafazatrom in man: effect on inhaled antigen challenge (English)

1 reference

2 August 2017

Fuller RW

1

1 reference

2 August 2017

Maltby N

2

1 reference

2 August 2017

Richmond R

3

1 reference

2 August 2017

Dollery CT

4

1 reference

2 August 2017

Taylor GW

5

1 reference

2 August 2017

Ritter W

6

1 reference

2 August 2017

Philipp E

7

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 June 1987

1 reference

British Journal of Clinical Pharmacology

2 August 2017

published in

1 reference

2 August 2017

volume

23

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

677-681

1 reference

Manipulation of the local thromboxane and prostacyclin balance in vivo by the antithrombotic compounds dazoxiben, acetylsalicylic acid and nafazatrom

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386161

Inhibition of phospholipase

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386161

Mediation of local homeostasis and inflammation by leukotrienes and other mast cell-dependent compounds

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386161

Prostaglandin D2 potentiates airway responsiveness to histamine and methacholine

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386161

Lung function and plasma levels of thromboxane B2, 6-ketoprostaglandin F1 alpha and beta-thromboglobulin in antigen-induced asthma before and after indomethacin pretreatment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386161

The antithrombotic activity of BAY g 6575

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386161

Leukotrienes are potent constrictors of human bronchi

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1987.TB03101.X

Partial flow-volume curves to measure bronchodilator dos-response curves in normal humans

21 January 2018

1 reference

12 December 2020

Nafazatrom (Bay g-6575), an antithrombotic and antimetastatic agent, inhibits 15-hydroxyprostaglandin dehydrogenase

1 reference

12 December 2020

The late reaction following bronchial provocation with house dust mite allergen. Dependence on arachidonic acid metabolism

1 reference

12 December 2020

Determination of nafazatrom in body fluids by high-performance thin-layer chromatography with post-chromatographic derivatization

1 reference

12 December 2020

Mechanism of the stimulation of prostaglandin H synthase and prostacyclin synthase by the antithrombotic and antimetastatic agent, nafazatrom

1 reference

12 December 2020

Inhibition of leukotriene B4 formation in human neutrophils after oral nafazatrom (Bay g 6575)

1 reference

12 December 2020

10.1111/J.1365-2125.1987.TB03101.X

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference